EXACT Sciences Corp. (EXAS)

106.71
NASDAQ : Health Technology
Prev Close 108.69
Day Low/High 106.06 / 109.27
52 Wk Low/High 53.06 / 123.99
Avg Volume 1.50M
Exchange NASDAQ
Shares Outstanding 129.49M
Market Cap 14.07B
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)
Get Your Head Into the Cloud: Cramer's 'Mad Money' Recap (Monday 5/22/17)

Get Your Head Into the Cloud: Cramer's 'Mad Money' Recap (Monday 5/22/17)

Jim Cramer says it's more than just the cloud. There are some astounding moves in the broader tech sector, too.

INVESTOR ALERT: Goldberg Law PC Announces An Investigation Of Exact Sciences Corporation

Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Exact Sciences Corporation ("Exact" or the "Company") (Nasdaq: EXAS).

Cook Tells Cramer: Apple to Launch $1B Tech Job Fund - Cramer's 'Mad Money' Recap (Wednesday 5/3/17)

Cook Tells Cramer: Apple to Launch $1B Tech Job Fund - Cramer's 'Mad Money' Recap (Wednesday 5/3/17)

Apple CEO says fund will boost advanced manufacturing in U.S.

Making Sense of Thursday's Flood of Biotech and Pharma Earnings Reports

Making Sense of Thursday's Flood of Biotech and Pharma Earnings Reports

A guide to keep track of all the companies reporting first quarter financial results today -- making sense of what's important and disregarding what's not.

Exact Sciences Stock Soaring on Aetna Cologuard Coverage

Exact Sciences Stock Soaring on Aetna Cologuard Coverage

Aetna now offers commercial coverage of Exact Sciences' Cologuard test.

Treehouse Foods, Arconic, Kinder Morgan, Chesapeake Energy: 'Mad Money' Lightning Round

Treehouse Foods, Arconic, Kinder Morgan, Chesapeake Energy: 'Mad Money' Lightning Round

Jim Cramer is bullish on Arconic, Treehouse Foods, Magellan Midstream Partners.

Trump's Tweet Creates Opportunity in Pharma: Cramer's 'Mad Money' Recap (Tuesday 2/7/17)

Trump's Tweet Creates Opportunity in Pharma: Cramer's 'Mad Money' Recap (Tuesday 2/7/17)

Jim Cramer says if Trump really wants to lower drug prices, he should target our trading partners.

T-Mobile, Verizon, Kellogg, Box, Best Buy : 'Mad Money' Lightning Round

T-Mobile, Verizon, Kellogg, Box, Best Buy : 'Mad Money' Lightning Round

Jim Cramer is bullish on T-Mobile, Box and Treehouse Foods. He's bearish on Verizon and Best Buy.

Don't Give Trump All the Credit for Market Gains: Cramer's 'Mad Money' Recap (Thursday 2/23/17)

Don't Give Trump All the Credit for Market Gains: Cramer's 'Mad Money' Recap (Thursday 2/23/17)

Jim Cramer knows this administration is pro-business, but Washington isn't the only place building business and market strength.

Analysts' Actions -- Discovery, First Solar, Momenta, VF Corp. and More

Analysts' Actions -- Discovery, First Solar, Momenta, VF Corp. and More

Here are Wednesday's top research calls, including downgrades for Discovery, First Solar and Momenta, and an upgrade for VF Corp.

Nasdaq Separates Itself From the Rest of the Market

Nasdaq Separates Itself From the Rest of the Market

Narrowing strength becomes a concern.

Major Indices' Support Holds, But Momentum Eases

Major Indices' Support Holds, But Momentum Eases

Biotech shares have gained from takeovers in that sector.

Bullish and Bearish Reversals for the Week

Bullish and Bearish Reversals for the Week

Here's a window into what institutional investors may be doing and how to profit from that.

Exact Sciences (EXAS) Stock Climbs, Colorectal Cancer Screening Guidelines Updated

Exact Sciences (EXAS) Stock Climbs, Colorectal Cancer Screening Guidelines Updated

Exact Sciences (EXAS) stock is gaining on Monday after the National Committee for Quality Assurance updated its guidelines on colorectal cancer screening tests.

2 Bullish Stock Picks and 2 Stocks to Sell Short

2 Bullish Stock Picks and 2 Stocks to Sell Short

Here's a look at two stocks that are trending higher and two that are ripe for short-selling.

EXAS: Insiders vs. Shorts

EXAS: Insiders vs. Shorts

The most recent short interest data was recently released for the 08/31/2016 settlement date, and EXACT Sciences Corp. is one of the most shorted stocks of the Russell 3000, based on 8.37 "days to cover" versus the median component at 6.39.

4 Breakout Stocks to Watch

4 Breakout Stocks to Watch

These four stocks are looking strong technically, either breaking out or approaching breakout levels.

10 Best-Performing Stocks This Earnings Season

10 Best-Performing Stocks This Earnings Season

Which stocks have had the highest gains following earnings? Bespoke Investment came up with a list of the 40 stocks that had the best performance on their earnings reaction days.

4 Tech and Biotech Stocks With Momentum to Watch

4 Tech and Biotech Stocks With Momentum to Watch

Here are four biotech and technology stocks showing strong technical momentum.

Exact Sciences (EXAS) Stock Falling After Public Offering

Exact Sciences (EXAS) Stock Falling After Public Offering

Exact Sciences (EXAS) announced today that it would be offering 8.5 million shares of common stock.

Exact Sciences Announces Agreement To Sell 7,000,000 Common Shares

Exact Sciences Announces Agreement To Sell 7,000,000 Common Shares

Exact Sciences Corporation (NASDAQ: EXAS) today announced an agreement to sell 7,000,000 shares of its common stock to Jefferies LLC, Robert W.

Strong On High Relative Volume: Exact (EXAS)

Strong On High Relative Volume: Exact (EXAS)

Trade-Ideas LLC identified Exact (EXAS) as a strong on high relative volume candidate

Exact Sciences (EXAS) Stock Soars on Q2 Earnings Beat

Exact Sciences (EXAS) Stock Soars on Q2 Earnings Beat

Exact Sciences (EXAS) is climbing today after the company reports better-than-expected 2016 second quarter earnings.

9-Day Churn Favors Upside Resolution

9-Day Churn Favors Upside Resolution

Tomorrow's FOMC decision is a convenient catalyst for a move.

Trade-Ideas: Exact (EXAS) Is Today's Post-Market Leader Stock

Trade-Ideas: Exact (EXAS) Is Today's Post-Market Leader Stock

Trade-Ideas LLC identified Exact (EXAS) as a post-market leader candidate

Exact Sciences (EXAS) Stock Rising on Illumina Takeover Speculation

Exact Sciences (EXAS) Stock Rising on Illumina Takeover Speculation

Shares of Exact Sciences (EXAS) are gaining after reports that the company may be acquired by Illumina (ILMN).

Exact (EXAS) Is Weak On High Volume Today

Exact (EXAS) Is Weak On High Volume Today

Trade-Ideas LLC identified Exact (EXAS) as a weak on high relative volume candidate

5 Hot Stocks to Watch Right Now

5 Hot Stocks to Watch Right Now

Biotech stocks continue to dominate our top stock charts to watch.

Exact (EXAS) Highlighted As Today's Perilous Reversal Stock

Exact (EXAS) Highlighted As Today's Perilous Reversal Stock

Trade-Ideas LLC identified Exact (EXAS) as a "perilous reversal" (up big yesterday but down big today) candidate

Exact (EXAS) Marked As A Dead Cat Bounce Stock

Exact (EXAS) Marked As A Dead Cat Bounce Stock

Trade-Ideas LLC identified Exact (EXAS) as a "dead cat bounce" (down big yesterday but up big today) candidate

TheStreet Quant Rating: C- (Hold)